Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
Published Online: 2024-05-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Bong-Ki Lee•Bong-Ki Lee•Chang-Wook Nam•Chang-Wook Nam Nam•David Smyth•David Smyth•Do-Yoon Kang•Do-Yoon Kang•Duk-Woo Park•Duk-Woo Park•Gary Mintz•Gary S Mintz•Gregg Stone•Gregg W Stone•Hiroki Shiomi•Hiroki Shiomi Shiomi•Hsien-Li Kao•Hsien-Li Kao•In-Ho Chae•In-Ho Chae•Jei Keon Chae•Jei-Keon Chae•Jin-Ok Jeong•Jin-Ok Jeong•Joo-Yong Hahn•Joo-Yong Hahn•Jung-Min Ahn•Jung-Min Ahn•Ki-Yuk Chang•Ki-Yuk Chang•Seung-Jung Park•Seung-Jung Park•Sung-Cheol Yun•Sung-Cheol Yun•Sung-Ho Her•Sung-Ho Her•Tae Hoon Ahn•Tae Hoon Ahn•Won-Jang Kim•Won-Jang Kim•Young-Keun Ahn•Young-Keun Ahn
